Catalyst Wire Dossier Catalyst Wire Dossier

ANGIOCOMB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ANGIOCOMB, covering 2014-05-08 to 2014-05-08. Get the full timeline:

Most recent: Clinical Trial Update: ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors [Phase 2]

See pricing